1 Min Read
April 4 (Reuters) - CanniMed Therapeutics Inc:
* CANNIMED HAS ENTERED INTO A LETTER OF INTENT TO BECOME PREFERRED SUPPLIER OF MEDICAL CANNABIS TO PHARMASAVE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.